Banner

Now enrolling in the CALM-2 clinical study
for patients with poorly controlled hypertension 

Reshaping Hypertension™ with the MobiusHD® System

Text

<h2><span style="color:#3598db">Hypertension impacts 1 billion people worldwide and the clinical consequences are devastating</span></h2>

List

<p>Reshaping of carotid sinus amplifies baroreceptor signaling to the brain</p>

Science, teamwork and scientist with tablet in laboratory for communication, pharmaceutical review or planning. Employees, collaboration and technology for research, discussion and digital analysis

AMPLIFY

<p>Significant blood pressure reduction demonstrated in multiple clinical studies.</p>

Asian people scientist in lab coat and protective gloves working with test tubes with green and red liquids, with microscope and other test tubes in the background in laboratory.

REDUCE

<p>Durable safety and efficacy at two-years</p>

medical writer or medical communicator are writing clinical trial documents that describe research results, product use, and other medical information.

LONG LASTING

<p>Minimally invasive access using endovascular techniques</p>

NON-SURGICAL

Text + image

<h3 style="white-space:pre-line"><span style="color:#3598db">Clinical Trials</span></h3>
<p>CALM-FIM  was a prospective, first-in-human, open-label study done at six sites in Europe. The MobiusHD system was studied in patients with an office systolic blood pressure ≥160 mmHg despite taking at least three antihypertensive agents, including a diuretic. </p>
<p>Results showed a significant decrease in mean ambulatory blood pressure in 73% of patients at 24 hours and blood pressure reduction of 21/12 mmHg at six months, as compared to baseline4.</p>

Location

Contact form

<h3>Contact Us</h3>
<p>Want to learn more about Vascular Dynamics or have a question about our approach? Use the contact form and let’s start a conversation.</p>